hotspot -WSS

hotspot

author：comprehensive 2025-10-02 21:06:40 - browse：94765

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why a market frenzy over new weight loss drugs defies logic

focus

WSS

How AI can help patients find reliable information about doctors

ADCs take center stage as promising cancer treatments

How the first Native Hawaiian psychiatrist helped diversify medicine

FDA clears Verve to begin U.S. study of gene

STAT Summit: The economic case for universal basic health care

Readout LOUD podcast: Live from the 2023 STAT Summit

hotspot

hotspot

Wikipedia

Affirmative action in medical school literally saved lives

Meadows told special counsel he could not recall Trump ever declassifying Mar

BioMarin wins approval for gene therapy to treat hemophilia A

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Sports medicine is finally prioritizing gender equality

How the drug

Trump demands the U.S. pay no more for drugs than other countries … again

DeSantis wants to import drugs. Biden’s FDA blasted his plan

The high cost of giving birth even with insurance

Abortion policy in the spotlight at Republican debate

entertainment

STAT Summit: The economic case for universal basic health care

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Can U.S. cancer drug shortages be fixed?

Cassava Sciences’ Alzheimer’s clinical trials should be halted

FDA clears Verve to begin U.S. study of gene

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

focus

explore

hotspot

hotspot